brazil
EN ES PT
Home
Welcome Note
Committees
Faculty
Timetable
Scientific Program
Satellite Symposia
Industry Advisory Board (IAB)
Abstract Submission
Poster Presentation
Poster Presentation Guidelines
List of Posters
Guided Poster Tours
Registration
Invitation Letter
Accommodation
CME
Sponsorship & Exhibition
Sponsors
Exhibitors
General Information
Tips and Hints
Transportation
Italian Agent
Chinese Agent
About Rio de Janeiro
Before you travel...
Endorsements
Partners
Previous and upcoming CODHy Congresses
The 2nd Latin America Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

Rio de Janeiro, Brazil, March 22-25, 2012
  Preliminary Scientific Program Print
Friday
 
Hall A
9:00-10:30
 
9:00-9:10
Plenary Session 1
Diabetes, Cardiovascular Diseases and Cancer
Congress Co-Chairpersons Introduction
J. Davidson, USA and I. Raz, Israel
9:10-9:30
Insulin resistance: A multifaceted disease responsible for ASCVD and cancer
R. A. DeFronzo, USA
9:30-9:50
Diabetes, obesity and cancer
S. Del Prato, Italy
9:50-10:10
Diabetes therapy and cancer
P. Home, UK
10:10-10:30
Overview of diabetes in Latin America
A. R. Chacra, Brazil

10:30-11:00
Coffee Break

11:00-12:30
Session 2
Prevention and Early Therapy
Chairs: A. R. Chacra, Brazil
           A. Golbert, Brazil
 
11:00-11:15
11:15-11:30
11:30-11:45
Prediabetes therapy: Lifestyle vs. Drugs
Lifestyle: J. Tuomilehto, Finland
Drugs: R.A. DeFronzo, USA
Discussion

11:45-12:00
12:00-12:15
12:15-12:30
First line therapy in T2D: Combination therapy vs. Monotherapy
Combination: P. Aschner, Colombia
Mono: A. Forti, Brazil
Discussion

12:30-13:30
Lunch Break

13:30-15:15
Session3
Utilization of Insulin Therapy by GPs
Chairs: E. Standl, Germany
           D. Abouganem, Panama
 
13:30-13:45
13:45-14:00
Are all sulfonylurea (Su) even?
Yes: L. Litwak, Argentina
No: R. Medina-Santillán, Mexico

14:00-14:15
14:15-14:30
Starting insulin therapy by GP: BASAL vs. Premix
BASAL: F. Lavalle, Mexico
Premix: B. Itzhak, Israel
 
14:30-14:45
14:45-15:00
15:00-15:15
Insulin intensification by GP
Yes: P. Pozzilli, Italy
No: C. Musso, Argentina
Discussion

15:15-15:45
Coffee Break

15:45-17:00
Session 4
The Voice of China
Chair: G. Ning, China
 
15:45-15:50
Chair Introduction
G. Ning, China
 
15:50-16:10
Treatment of Type 2 diabetes with traditional Chinese medicine
G. Ning, China
 
 
16:10-16:25
Relationship of Urinary Bisphenol A Concentration to Risk for Prevalent Type 2 Diabetes in Chinese Adults
Y. Bi, China
 
 
16:25-16:40
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
G. Li, China
 
 
 
16:40-16:55
Stratifying and tailoring HbA1c control targets for adults with Type 2 diabetes: Interpretation of the consensus proposed by the Chinese Society of Endocrinology
N. Tong, China
 
16:55-17:00
Concluding remarks
G. Ning, China

 
Hall B
11:00-12:30
Session 5
Hypertension Controversies
Chair: Y. Sharabi, Israel
 
11:00-11:15
11:15-11:30
11:30-11:45
Should we change the target blood pressure in diabetic patients?
Yes: A. Ramirez, Argentina
No: G.C. Aylwin, Chile
Discussion
 
11:45-12:00
12:00-12:15
12:15-12:30
Should we avoid antihypertensive drugs that increase glucose/ obesity?
Yes: G.D. Waisman, Argentina
No: R. Lyra, Brazil
Discussion

12:30-13:30
Lunch Break

13:30-15:15
Session 6
RAAS in Diabetes
Chair: G. Waisman, Argentina
 
13:30-13:50
Is intracellular RAAS blockade a therapeutic target?
M. Gironacci, Argentina
 
13:50-14:10
ACEs, ARBs or DRI: What is the best choice?
A. Ramirez, Argentina
 
14:10-14:30
14:30-15:15
Is RAAS blockade indicated in every (T2D) patient
Y. Sharabi, Israel
Discussion
 
Oral Presentations
 
 
14:30-14:40
Impact of soy consumption on hypertension in women: A case study
from a low-income rural community in South Africa
W. Oldewage-Theron
South Africa,A. Egal
 
 
14:40-14:50
Who are indicated for a glucose tolerance test among hypertensive patients?
Y.K. Kim
, South Korea, Y.S. Kim, M.K. Lee, M.Y. Rhee, E.J. Cho, B.J. Kwon,
K.C. Sung, M.S. Hyon
14:50-15:15
Discussion

15:15-15:45
Coffee Break
 
15:45-17:00
Session 7
Meet the Professor: Metabolic Syndrome
Chairs: E. Gruber de Bustos, Venezuela
           J. E. Paolo de Oliveira, Brazil 

15:45-16:05
Metabolic Syndrome: Do we need this definition?
W. Coutinho, Brazil 
 
16:05-16:25
 
Testosterone for the management of Metabolic Syndrome
F. Saad, Germany
 
 
16:25-16:40
16:49-16:55

Intolerance to statin/ target HDL

Yes: R. Lyra, Brazil

 No: R. Eldor, Israel

16:55-17:00
Discussion
 
Hall C
11:00-12:30
Session 8
Obesity
Chair: S. Klein, USA 
 
11:00-11:20
Current and future non-surgical weight loss therapy
S. Klein, USA
 

11:20-11:35
Are there weight loss-independent effects of upper gastrointestinal tract diversion on diabetes?
R. Cohen, Brazil

11:35-11:50
How good is sleeve gastrectomy?
C. Boza, Chile

11:50-12:05
12:05-12:30
Bio Markers in diabetes and obesity
B. Wajchenberg, Brazil
Discussion
 
12:30-13:30
Lunch Break
 
13:30-15:15
Session 9
Insulin Resistance/Beta Cell Role in Diabetes Progression
Chairs: R. A. DeFronzo, USA
           L. Zagury, Brazil
 
13:30-13:55
Tools to assess insulin resistance and Beta Cell function
M. Saad, Brazil
 
 
13:55-14:20
Beta function:Evaluation and clinical applications
J.J. Gagliardino, Argentina
 
 
14:20-14:45
14:45-15:15
Insulin secretion and Insulin resistance: A dynamic interaction
R.A. DeFronzo, USA
Discussion

15:15-15:45
Coffee Break
 
15:45-17:00
Session 10
New Insights to Neuropathy in T2D
Chair: R. Niecestro, USA 
 
15:45-16:00
16:00-16:10
Peripheral Neuropathy and small fibers: Diagnosis and therapeutic approach
H. C. Pedrosa, Brazil
Discussion
 
16:10-16:25
16:25-16:35
CAN: A tool to assess the diagnosis by the diabetologist
C. Rolim, Brazil
Discussion
 
16:35-16:50
16:50-17:00
The brain: New insights with diabetes, Alzheimer and depression
R. Moreira, Brazil
Discussion
 
17:00-19:00
SGLT2 Inhibition and the ‘CODHy’ Controversies: Glycaemic Control and Beyond
Satellite Symposium sponsored by Bristol-Myers Squibb & AstraZeneca
This educational programme is accredited by the Royal College of Physicians of the United Kingdom for 2 credits

 

Home    Contact Us   
 
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 05/13/2012 Created by     WebStudio.co.il